Palliative Management of Inoperable Malignant Bowel Obstruction: A Prospective, Open Label, Phase-2 Study at an NCI Comprehensive Cancer Center
Condition: Malignant Bowel Obstruction Interventions: Drug: Dexamethasone; Drug: Metoclopramide; Drug: Octreotide Sponsors: Roswell Park Cancer Institute; National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2019 Category: Research Source Type: clinical trials
Palliative Management of Inoperable Malignant Bowel Obstruction
Condition: Malignant Bowel Obstruction Interventions: Drug: Dexamethasone; Drug: Metoclopramide; Drug: Octreotide Sponsors: Roswell Park Cancer Institute; National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2019 Category: Research Source Type: clinical trials
Palliative Management of Inoperable Malignant Bowel Obstruction: A Prospective, Open Label, Phase-2 Study at an NCI Comprehensive Cancer Center
Condition: Malignant Bowel Obstruction Interventions: Drug: Dexamethasone; Drug: Metoclopramide; Drug: Octreotide Sponsors: Roswell Park Cancer Institute; National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2019 Category: Research Source Type: clinical trials